GOLDENTREE ASSET MANAGEMENT LP bought 145,716 shares of Keenova Therapeutics plc on Nov 5, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
10% owner
10%
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
145,716Ordinary Shares
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
1.7%This security and ownership context
Holdings after
8,725,543Indirect · See footnotes
Trade date
Nov 5, 2026Buy
Filed
Nov 9, 2026, 5:30 PM ET4-day reporting delay
Accession
0001493152-26-050818Code P · Transaction 396319
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 8,579,827 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 6, 2026Buy150,000——Trade 396320
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

NONE price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NONE · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: This Form 4 is filed on behalf of GoldenTree Asset Management LP (the "Advisor"), GoldenTree Asset Management LLC (the "General Partner") and Steven A. Tananbaum (collectively, the "Reporting Persons"). The Advisor is the investment manager or advisor to certain funds and separate accounts managed by the Advisor (the "Funds") and may be deemed to have a pecuniary interest in the securities directly held by the Funds. The General Partner is the general partner of the Advisor and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor has a pecuniary interest. Steven A. Tananbaum is the managing member of the General Partner and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor and the General Partner have a pecuniary interest. F2: The Advisor, the General Partner, and Mr. Tananbaum disclaim beneficial ownership of the Ordinary Shares held by the Funds. F3: The securities reported herein include 8,821,928 Ordinary Shares held directly by certain funds and separate accounts managed by the Advisor and 53,615 Ordinary Shares held directly by Mr. Tananbaum.